Amgen Inc. buy Royal Bank of Canada
Start price
15.01.26
/
50%
€284.25
Target price
15.01.27
€287.83
Performance (%)
8.10%
Price
02.04.26
€301.70
Summary
This prediction is currently active. With a performance of 8.10%, the BUY prediction by Royal_Bank_of_Canada for Amgen Inc. is trending in the right direction. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 15.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -1.758% | -1.758% |
| iShares Core DAX® | 2.489% | -5.941% |
| iShares Nasdaq 100 | 1.649% | -2.462% |
| iShares Nikkei 225® | 0.555% | -7.597% |
| iShares S&P 500 | 1.347% | -2.943% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $330.00 to $335.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat